Search

everythinglearnresearchcommunity

for

Search:↓

New factors in female hair loss include genetics, hormones, stress, and inflammation; future treatments should also focus on these areas and consider the patient's emotional well-being.

The woman has a skin condition involving nodules, scars, and hair loss.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

New compounds may help treat heart disease by activating specific potassium channels.

Janus kinase inhibitors effectively treat alopecia areata but may cause relapses and have long-term safety concerns.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

JAK inhibitors are effective treatments for alopecia areata.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

OR-101 shows promise for treating alopecia areata by improving hair growth.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

JAK inhibitors show promise in treating moderate to severe alopecia areata.

Applying a specific inhibitor lightens skin and hair color.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

Axitinib treatment turned a man's grey hair back to black.

Long-term oral and topical treatments improved skin condition in a goldendoodle with a genetic disorder.

ICD codes for skin conditions vary in accuracy, needing better validation for some common conditions.

The LED light therapy mask improved skin elasticity and reduced signs of aging in a test and in women aged 40-60.

JAK inhibitors are effective for severe alopecia areata but need better strategies for long-term use and personalized treatment.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Switching Janus kinase inhibitors helped some patients with severe alopecia areata regrow hair, but insurance issues can worsen the condition.

New pyridine compounds effectively inhibit GSK3, a diabetes treatment target.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

JAK inhibitors for alopecia areata have different safety risks, requiring specific monitoring for each drug.

Dauricine may help treat certain brain cancers by reducing cancer cell growth and promoting cell death.